Lionel D Lewis

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 10

Top Topics

Drug Administration

Placebo Controlled

Top Venues

British journal of clinical pharmacology

International journal of molecular sciences

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

David W Nierenberg, Lionel D Lewis
The clinical pharmacology and therapeutics course for graduating medical students at Dartmouth: Preparation for internship and residency. British journal of clinical pharmacology (2024)
Junghoon Lee, Adrianna L De La Torre, Felix L Rawlinson, Dylan B Ness, Lionel D Lewis, William F Hickey, Catherine C Y Chang, Ta Yuan Chang
Characterization of Stealth Liposome-Based Nanoparticles Encapsulating the ACAT1/SOAT1 Inhibitor F26: Efficacy and Toxicity Studies In Vitro and in Wild-Type Mice. International journal of molecular sciences 25 (17) (2024)
Dylan B Ness, Darcy B Pooler, Steven Ades, Brian J Highhouse, Bridget M Labrie, Anne G Hoen, Jiang Gui, Lionel D Lewis, Marc S Ernstoff
A phase II study of alternating sunitinib and temsirolimus therapy in patients with metastatic renal cell carcinoma. Cancer medicine (2023)
Adrianna L De La Torre, Thao N Huynh, Catherine C Y Chang, Darcy B Pooler, Dylan B Ness, Lionel D Lewis, Sanjana Pannem, Yichen Feng, Kimberley S Samkoe, William F Hickey, Ta Yuan Chang
Stealth Liposomes Encapsulating a Potent ACAT1/SOAT1 Inhibitor F12511: Pharmacokinetic, Biodistribution, and Toxicity Studies in Wild-Type Mice and Efficacy Studies in Triple Transgenic Alzheimer's Disease Mice. International journal of molecular sciences 24 (13) (2023)
Robert Likić, James W Dear, Lionel D Lewis
Spotlight commentary: Navigating between financial risks and improved treatment outcomes with immune checkpoint inhibitors in cancer patients: The need for biomarker identification and dose optimization. British journal of clinical pharmacology 88 (12) (2022)
Joseph D Phillips, Darcy B Pooler, Dylan B Ness, Kayla Fay, Steven Tau, Eugene Demidenko, Riley A Hampsch, Lionel D Lewis, Todd W Miller
Tumour, whole-blood, plasma and tissue concentrations of metformin in lung cancer patients. British journal of clinical pharmacology (2022)
Darcy B Pooler, Dylan B Ness, Alexey V Danilov, Bridget M Labrie, Tor D Tosteson, Alan Eastman, Lionel D Lewis, Frederick Lansigan
A phase I trial of BNC105P and ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia. EJHaem 3 (4) (2022)
Jennifer H Martin, Lionel D Lewis
Taking the brake off the immune system: Hypotheses, trials, tribulations, and the evolving discipline of clinical immunopharmacology. British journal of clinical pharmacology 86 (9) (2020)
Lionel D Lewis
Medicamenta ad sentinam, et defectum vitae: Drugs and failure of the pump of life-cardiotoxicity of oncotherapeutics. British journal of clinical pharmacology 87 (3) (2020)
Darcy B Pooler, Dylan B Ness, John Sarantopoulos, Nicholas Squittieri, Shoba Ravichandran, Carolyn D Britten, Ravi K Amaravadi, Ulka Vaishampayan, Patricia LoRusso, Geoffrey I Shapiro, Anthony J Olszanski, Raymond P Perez, Martin Gutierrez, Mark Allen O'Rourke, Vincent Chung, James J Lee, Lionel D Lewis
The effect of sonidegib (LDE225) on the pharmacokinetics of bupropion and warfarin in patients with advanced solid tumours. British journal of clinical pharmacology 87 (3) (2020)